Boston Scientific Allowance for Doubtful Accounts decreased by 3.8% to $127.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.4%, from $113.00M to $127.00M. Over 5 years (FY 2020 to FY 2025), Allowance for Doubtful Accounts shows an upward trend with a 4.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests rising credit risk or economic stress among the customer base.
A contra-asset account that represents the estimated portion of accounts receivable that the company does not expect to...
Standard across all utilities; levels are often influenced by regulatory mandates regarding service disconnection policies.
allowance_for_doubtful_accounts| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $107.00M | $108.00M | $108.00M | $113.00M | $117.00M | $114.00M | $109.00M | $118.00M | $127.00M | $126.00M | $110.00M | $109.00M | $105.00M | $109.00M | $109.00M | $113.00M | $112.00M | $133.00M | $132.00M | $127.00M |
| QoQ Change | — | +0.9% | +0.0% | +4.6% | +3.5% | -2.6% | -4.4% | +8.3% | +7.6% | -0.8% | -12.7% | -0.9% | -3.7% | +3.8% | +0.0% | +3.7% | -0.9% | +18.8% | -0.8% | -3.8% |
| YoY Change | — | — | — | — | +9.3% | +5.6% | +0.9% | +4.4% | +8.5% | +10.5% | +0.9% | -7.6% | -17.3% | -13.5% | -0.9% | +3.7% | +6.7% | +22.0% | +21.1% | +12.4% |